Informations techniques
Exploitant
ARROW GENERIQUES
Présentation
TERBUTALINE ARROW 5 mg/2 ml, solution pour inhalation par nébuliseur en récipient unidose
Boîte de 50 récipients unidoses de 2 ml (code CIP: 365 790-1)
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
x24Ryg1TA5hv6M6e